Back to search

Article

Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR Signaling Pathways

2024-03-17

Abstract excerpt

Metformin (MET) is a preferred drug for the treatment of type 2 diabetes mellitus. Recent studies show that apart from its blood glucose-lowering effects, it also inhibits the development of various tumours, by inducing autophagy. Various studies have confirmed the inhibitory effects of MET on cancer cell lines’ propagation, migration, and invasion. The objective of the study was to comprehensively review the pote...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d5573b3e-0d42-5c8b-8643-3df2c7a29906
DOI
10.22541/au.171065529.99191979/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effects of metformin on cancers in experimental and clinical studies: Focusing on autophagy and AMPK/mTOR Signaling PathwaysDOI 10.22541/au.171065529.99191979/v1
Select a neighboring publication to make it the new centre.